Relief of symptoms after gefitinib is associated with improvement of rest/activity rhythm in advanced lung cancer

J Clin Oncol. 2007 Jun 1;25(16):e17-9. doi: 10.1200/JCO.2007.11.3274.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / physiopathology
  • Carcinoma, Non-Small-Cell Lung / psychology
  • Circadian Rhythm*
  • Gefitinib
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / physiopathology
  • Lung Neoplasms / psychology
  • Quality of Life
  • Quinazolines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Quinazolines
  • Gefitinib